BDBM251712 US10100018, Example 48::US9464060, 48

SMILES COc1cccc(Oc2ccc(cc2)C(=O)N(CCc2ccccc2)Cc2ccc(cc2)C(O)=O)c1

InChI Key InChIKey=MIVMJXVFYIKSJK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 251712   

TargetLysophosphatidic acid receptor 5(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM251712(US9464060, 48 | US10100018, Example 48)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:Engagement of the LPA5 receptor by its ligand, oleoyl-L- ±-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM251712(US9464060, 48 | US10100018, Example 48)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2019
Entry Details
US Patent